drugset / Trial / NCT04322526

Study of Naltrexone-Induced Blockade of Antidepressant Effects

NCT04322526

RandomizedCrossoverDouble-blindBasic science

Summary

The goal of this study is to determine whether antidepressant placebo effects and contextual cues broadly, can be blocked by one single dose of the µ-opioid antagonist naltrexone. To test this hypothesis, un-medicated, patients with MDD completed a randomized, double-blind, placebo-controlled, cross-over study of 50mg of the µ-opioid antagonist naltrexone or matching placebo, immediately before a Pharmaco-fMRI scanning session.

Timeline

Start
2017-07-01
Primary completion
2018-07-15
Completion
2018-07-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Naltrexone Small molecule 50 mg Oral